Wall Street Navigates Fed Meeting and Strong Retail Sales as Indexes Hover Near Records
Stock Market News· 2025-09-16 20:07
Market Overview - The U.S. stock market closed on September 16, 2025, with major indexes near all-time highs, driven by strong retail sales data and anticipation of the Federal Reserve's policy meeting [1][3] - The S&P 500 Index decreased by 0.1%, while the Nasdaq Composite finished up less than 0.1%, and the Dow Jones Industrial Average dipped between 0.2% and 0.3% [2] Economic Data - U.S. retail sales for August increased by 0.6% month-over-month, exceeding expectations of 0.3%, with July's figures revised to a 0.6% growth [5] - Upcoming economic releases include Housing Starts and Building Permits, which will provide insights into the housing market's health [6] Federal Reserve Meeting - The Federal Open Market Committee (FOMC) meeting is expected to conclude with a widely anticipated 25-basis-point reduction in the federal funds rate, aimed at boosting economic activity [4] Corporate Developments - Alphabet (GOOGL) shares rose, reaching a market capitalization above $3 trillion, following Citigroup's price target increase to $280 from $225 [7] - Tesla (TSLA) shares increased over 3% after Elon Musk's $1 billion stock purchase [7] - Emerson Electric (EMR) shares fell nearly 5% due to disappointing fiscal fourth-quarter orders guidance [8] - Webtoon Entertainment's shares soared 28% after a deal with Disney for a new digital comics platform [9] Upcoming Earnings Reports - General Mills (GIS) is set to report earnings, with other notable companies like FedEx (FDX), Micron Technology (MU), Accenture (ACN), Costco Wholesale (COST), and Nike (NKE) scheduled for later in September [12]
GE Vernova Stock Has Two Things Going For It
Barrons· 2025-09-16 20:07
Baird analyst Ben Kallo recently reviewed GE Vernova's heavy duty and aeroderivative turbine businesses. ...
Is IonQ the NVIDIA of Tomorrow, and Should You Buy the Stock?
ZACKS· 2025-09-16 20:06
Key Takeaways IonQ's qubits boost accuracy versus rivals, with systems running at room temperature to cut costs.Partnerships with AWS, Azure and GCP, plus acquisitions, expand IonQ's quantum ecosystem.Q2 revenue hit $20.7M, but a $177.5M net loss highlights IonQ's ongoing profitability challenge.The way NVIDIA Corporation (NVDA) benefited from the artificial intelligence (AI) boom to become a $4 trillion behemoth, a smaller company, IonQ, Inc. (IONQ) , is aiming to do the same by taking advantage of the nex ...
Robinhood Stock Is Climbing Tuesday: What's Going On?
Benzinga· 2025-09-16 20:06
Robinhood Markets Inc HOOD shares are trading higher on Tuesday afternoon, amid the recent release of encouraging operating data for August 2025 and the announcement of a new fund aimed at democratizing access to private markets.HOOD is demonstrating bullish strength. Check the analyst take here.What To Know: The company reported a year-over-year increase in funded customers, which grew by 11% to 26.7 million. Total platform assets also saw a significant jump, rising 112% from the previous year to $304 bill ...
Empire State Realty Trust Announces Dates for Third Quarter 2025 Earnings Release and Conference Call
Businesswire· 2025-09-16 20:05
NEW YORK--(BUSINESS WIRE)--Empire State Realty Trust, Inc. (NYSE: ESRT) (the "Company†), today announced that it will release its third quarter 2025 financial results on Wednesday, October 29, 2025, after the close of markets on the New York Stock Exchange. A conference call will be held on Thursday, October 30, 2025, at 12:00 p.m. Eastern Time. During the conference call, the Company's officers will review third quarter performance, discuss recent events and conduct a question-and-answer perio. ...
Wall Street hates REITs — why that might be good news for you
MarketWatch· 2025-09-16 20:05
If history is any guide, that's a positive sign for investors. ...
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
Accessnewswire· 2025-09-16 20:05
DENVER, CO / ACCESS Newswire / September 16, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will report its operational and financial results for its fiscal 2025 full year and fourth quarter, after the market close on Tuesday, September 23, 2025. The Company has scheduled a conference call and webcast that same day, Tuesday, Septemb ...
IR-MED Investor Update Letter - Sept-2025
Newsfile· 2025-09-16 20:05
Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial intelligence (AI)-powered spectrographic technology to address critical healthcare challenges, today published an investor update. Dear Valued Investors,As we enter September 2025, in addition to Q2 financial reports and to the 8K recently published, I find it appropriate to update you on the developments within our Company. As you will see from the inform ...
Heidrick & Struggles to Participate in William Blair's Inaugural Human Capital Services Virtual Conference
Prnewswire· 2025-09-16 20:05
Accessibility StatementSkip Navigation Heidrick & Struggles Delivers 14% Revenue Growth in Q2, Driving Strong Profitability Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global... Heidrick & Struggles to Release 2025 Second Quarter Results CHICAGO, Sept. 16, 2025 /PRNewswire/ -- Heidrick & Struggles International, Inc. (Nasdaq: HSII) ("Heidrick & Struggles", "Heidrick" or the "Company"), a premier provider of global leade ...
Neurocrine Biosciences to Present New Data from Phase 2 Study of Osavampator in Adults with Major Depressive Disorder at 38th Annual Psych Congress 2025
Prnewswire· 2025-09-16 20:05
Additional Data from SAVITRIâ"¢ Study Expand on Top-Line Results Announced in April 2024 SAVITRI Poster Presentation Chosen as Finalist for Psych Congress Poster Awards SAN DIEGO , Sept. 16, 2025 /PRNewswire/ --Â Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from the Phase 2 SAVITRI study of osavampator in adults with major depressive disorder at Psych Congress 2025, taking place September 17-21 in San Diego. ...